Download - WHOCC

QD
DERMATOLOGICALS
This main group comprises dermatological preparations. Most of these preparations
are intended for topical use, e.g. antifungals, antibiotics, corticosteroids and
antiseptics for topical use.
Some dermatological preparations intended for systemic use, e.g. griseofulvin
(antimycotic), are also classified in this group.
QD01
ANTIFUNGALS FOR DERMATOLOGICAL USE
Preparations for topical and systemic treatment of dermatological mycoses should
be classified in this group. Preparations with a systemic antimycotic effect, see also
QJ02A - Antimycotics for systemic use.
Preparations for local treatment of fungal infections in the mouth, see
QA01AB - Antiinfectives and antiseptics for local oral treatment.
QD01A
ANTIFUNGALS FOR TOPICAL USE
Combined preparations are assigned in this group if mycosis is regarded the main
indication.
QD01AA
Antibiotics
Preparations used in the treatment of bacterial dermatological infections, see
QD06A - Antibiotics for topical use.
QD01AC
Imidazole and triazole derivatives
Shampoos containing imidazoles are classified in this group.
Combinations with corticosteroids are classified in QD01AC20. All other
combinations are classified by using the 50-series e.g. miconazole and zinc.
Combinations of clotrimazole, gentamicin and corticosteroids are classified in
QD07C.
QD01AE
Other antifungals for topical use
Combined preparations containing salicylic acid used as antifungals (e.g. dusting
powders) are classified in this group using the 5th level code QD01AE20 - other
fungals for topical use. See also QD02AF - Salicylic acid preparations for topical
use, and QD08AH - Quinolone derivatives (chlorquinaldol, clioquinol etc.).
61